Amanda Feilding
Executive Director and Founder
Key Impact
Innocative figure in psychedelic research and founder of the Beckley Foundation.
Background & Research
Amanda Feilding (1943–2025) was a British drug policy reformer and the founder of the Beckley Foundation. Often described as the 'hidden hand' behind the psychedelic renaissance, she dedicated her life to the study of consciousness and the scientific validation of psychedelics. Through the Beckley Foundation, she collaborated on many of the first modern human studies with LSD, psilocybin, and MDMA.
Collaboration Network
71 collaborators· click a node to visit their profile
Full network →Compounds
Topics
Healthy VolunteersNeuroimaging & Brain MeasuresDepressive DisordersAnxiety DisordersSubstance Use Disorders (SUD)MicrodosingChronic PainSchizophreniaHeadache Disorders (Cluster & Migraine)Set & SettingPersonality & Trait FactorsTreatment-Resistant Depression (TRD)Palliative & End-of-Life DistressMedicinal Chemistry & Drug DevelopmentCreativityImmunology & InflammationPTSDNeurocognitive DisordersMajor Depressive Disorder (MDD)Obsessive-Compulsive Disorder (OCD)Safety & Risk ManagementInterpersonal Functioning & Social ConnectednessBorderline Personality Disorder (BPD)Personality DisordersEquity and EthicsNeurological InjuryOlder AdultsFibromyalgiaAdolescentsAlcohol Use Disorder (AUD)Tobacco/Nicotine Use Disorder (TUD)